Bristol-Myers Squibb Is A Good Pick

Core Insights - The stock of Bristol-Myers Squibb Company (NYSE: BMY) has declined approximately 14% since December 2024 and nearly 25% over the last year [1] Group 1: Company Analysis - The analysis focuses on high-quality companies that can outperform the market in the long run due to competitive advantages and high defensibility [1] - The analyst has a background in sociology, holding a Master's Degree with an emphasis on organizational and economic sociology, and a Bachelor's Degree in Sociology and History [1]